RVMD Revolution Medicines topped premarket movers today after weekend data showed 52% response rates in lung cancer trials. The biotech grabbed trader attention with May and June expiries stacking up as bulls positioned ahead of momentum.
XENE Xenon Pharma surged on Phase 3 epilepsy data showing 53% seizure reduction. Options chains loaded through July as traders anticipated follow-through. The $3B neuroscience name held dense near-term expiry calendars suggesting aggressive directional bets.
ASTS AST SpaceMobile absorbed weekend satellite news with eight separate expiries through July. Weekly expirations dominated showing short-term volatility positioning. The space stock faced orbital setback yet maintained heavy options interest.
BLD TopBuild jumped 20% premarket on undisclosed catalysts. May through July expiries showed standard quarterly structure. QXO QXO held seven consecutive weekly expiries signaling active swing trading.
Semiconductor names led options sentiment rankings. AXT grabbed top position with 405% year-to-date gains drawing momentum traders. Amkor Technology and SiTime followed with RSI above 76 indicating overbought conditions yet sustained call interest.
CLSK CleanSpark and Core Scientific held elevated options scores as crypto mining exposure attracted volatility players. Nokia maintained second-place positioning from prior weeks showing persistent telecom rotation flows.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
